Table of Contents
Epilepsy Research and Treatment
Volume 2012 (2012), Article ID 809843, 12 pages
http://dx.doi.org/10.1155/2012/809843
Review Article

Depression in Temporal Lobe Epilepsy: A Review of Prevalence, Clinical Features, and Management Considerations

Department of Psychiatry, Schulich School of Medicine, University of Western Ontario, London, ON, Canada N6A 5C1

Received 4 July 2011; Accepted 10 September 2011

Academic Editor: Warren T. Blume

Copyright © 2012 C. S. Garcia. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Kondziella, S. Alvestad, A. Vaaler, and U. Sonnewald, “Which clinical and experimental data link temporal lobe epilepsy with depression?” Journal of Neurochemistry, vol. 103, no. 6, pp. 2136–2152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. W. A. M. Swinkels, J. Kuyk, R. van Dyck, and P. Spinhoven, “Psychiatric comorbidity in epilepsy,” Epilepsy & Behavior, vol. 7, no. 1, pp. 37–50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Pond and B. H. Bidwell, “A survey of epilepsy in fourteen general practices: II. Social and psychological aspects,” Epilepsia, vol. 1, pp. 285–299, 1960. View at Google Scholar
  4. O. Gureje, “Interictal psychopathology in epilepsy: prevalence and pattern in a Nigerian clinic,” The British Journal of Psychiatry, vol. 158, pp. 700–705, 1991. View at Google Scholar · View at Scopus
  5. F. A. Gibbs, E. L. Gibbs, and B. Furster, “Psychomotor epilepsy,” Archives of Neurology and Psychiatry, vol. 60, pp. 331–339, 1948. View at Google Scholar
  6. G. Gudmundsson, “Epilepsy in Iceland,” Acta Neurologica Scandinavica, vol. 43, supplement 25, pp. 1–124, 1966. View at Google Scholar · View at Scopus
  7. E. A. Rodin, M. Katz, and K. Lennox, “Differences between patients with temporal lobe seizures and those with other forms of epileptic attacks,” Epilepsia, vol. 17, no. 3, pp. 313–320, 1976. View at Google Scholar · View at Scopus
  8. C. L. Harden, “The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment,” Neurology, vol. 59, no. 6, supplement 4, pp. S48–S55, 2002. View at Google Scholar · View at Scopus
  9. R. Manchanda, B. Schaefer, R. S. McLachlan, and W. T. Blume, “Interictal psychiatric morbidity and focus of epilepsy in treatment refractory patients admitted to an epilepsy unit,” The American Journal of Psychiatry, vol. 149, no. 8, pp. 1096–1098, 1992. View at Google Scholar · View at Scopus
  10. W. A. M. Swinkels, J. Kuyk, E. H. De Graaf, R. van Dyck, and P. Spinhoven, “Prevalence of psychopathology in Dutch epilepsy inpatients: a comparative study,” Epilepsy & Behavior, vol. 2, no. 5, pp. 441–447, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. G. Small, I. F. Small, and M. P. Hayden, “Further psychiatric investigations of patients with temporal and nontemporal lobe epilepsy,” The American Journal of Psychiatry, vol. 123, no. 3, pp. 303–310, 1966. View at Google Scholar · View at Scopus
  12. J. R. Stevens, “Psychiatric implications of psychomotor epilepsy,” Archives of General Psychiatry, vol. 14, no. 5, pp. 461–471, 1966. View at Google Scholar · View at Scopus
  13. R. J. Mignone, E. F. Donnelly, and D. Sadowsky, “Psychological and neurological comparisons of psychomotor and non-psychomotor epileptic patients,” Epilepsia, vol. 11, no. 4, pp. 345–359, 1970. View at Google Scholar · View at Scopus
  14. K. F. Standage and G. W. Fenton, “Psychiatric symptom profiles of patients with epilepsy: a controlled investigation,” Psychological Medicine, vol. 5, no. 2, pp. 152–160, 1975. View at Google Scholar · View at Scopus
  15. S. J. Adams, T. J. O'Brien, J. Lloyd, C. J. Kilpatrick, M. R. Salzberg, and D. Velakoulis, “Neuropsychiatric morbidity in focal epilepsy,” The British Journal of Psychiatry, vol. 192, no. 6, pp. 464–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Sanchez-Gistau, L. Pintor, G. Sugranyes et al., “Prevalence of interictal psychiatric disorders in patients with refractory temporal and extratemporal lobe epilepsy in Spain. A comparative study,” Epilepsia, vol. 51, no. 7, pp. 1309–1313, 2010. View at Google Scholar
  17. W. A. M. Swinkels, W. van Emde Boas, J. Kuyk, R. Van Dyck, and P. Spinhoven, “Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE,” Epilepsia, vol. 47, no. 12, pp. 2092–2103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. B. P. Hermann, S. Dikmen, and A. J. Wilensky, “Increased psychopathology associated with multiple seizure types: fact or artifact?” Epilepsia, vol. 23, no. 6, pp. 587–596, 1982. View at Google Scholar · View at Scopus
  19. C. B. Dodrill, “Number of seizure types in relation to emotional and psychological adjustment in epilepsy,” in Advances in Epileptology, R. J. Porter, A. A. Ward Jr., R. H. Mattson, and M. Dam, Eds., Epilepsy International Symposium, pp. 541–544, Raven Press, New York, NY, USA, XVth edition, 1984. View at Google Scholar
  20. J. R. Stevens and B. P. Hermann, “Temporal lobe epilepsy, psychopathology, and violence: the state of the evidence,” Neurology, vol. 31, no. 9, pp. 1127–1132, 1981. View at Google Scholar · View at Scopus
  21. B. P. Hermann and S. Whitman, “Behavioral and personality correlates of epilepsy: a review, methodological critique, and conceptual model,” Psychological Bulletin, vol. 95, no. 3, pp. 451–497, 1984. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Robertson, S. Channon, and J. Baker, “Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: a controlled study,” Epilepsia, vol. 35, no. 4, pp. 771–777, 1994. View at Google Scholar · View at Scopus
  23. A. Indaco, P. B. Carrieri, C. Nappi, S. Gentile, and S. Striano, “Interictal depression in epilepsy,” Epilepsy Research, vol. 12, no. 1, pp. 45–50, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. D. C. Hesdorffer, W. A. Hauser, J. F. Annegers, and G. Cascino, “Major depression is a risk factor for seizures in older adults,” Annals of Neurology, vol. 47, no. 2, pp. 246–249, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Reilly, S. Bowden, F. Bardenhagen, and M. Cook, “Equality of the psychological model underlying depressive symptoms in patients with temporal lobe epilepsy versus heterogeneous neurological disorders,” Journal of Clinical and Experimental Neuropsychology, vol. 28, no. 7, pp. 1257–1271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Blumer, S. Wakhlu, K. Davies, and B. Hermann, “Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications,” Epilepsia, vol. 39, no. 5, pp. 478–486, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Devinsky and S. Najjar, “Evidence against the existence of a temporal lobe personality syndrome,” Neurology, vol. 53, no. 2, pp. 513–525, 1999. View at Google Scholar · View at Scopus
  28. D. M. Bear and P. Fedio, “Quantitative analysis of interictal behavior in temporal lobe epilespy,” Archives of Neurology, vol. 34, no. 8, pp. 454–467, 1977. View at Google Scholar · View at Scopus
  29. D. Blumer, “Evidence supporting the temporal lobe epilepsy personality syndrome,” Neurology, vol. 53, no. 2, pp. S9–S12, 1999. View at Google Scholar · View at Scopus
  30. A. M. Kanner, A. M. Kozak, and M. Frey, “The use of sertraline in patients with epilepsy: is it safe?” Epilepsy & Behavior, vol. 1, no. 2, pp. 100–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Carson, A. Zemen, and M. C. Sharpe, “Neurology and neurosurgery,” in Textbook of Psychosomatic Medicine, J. L. Levenson, Ed., chapter 32, pp. 759–795, American Psychiatric Publishing, Washington, DC, USA, 2nd edition, 2011. View at Google Scholar
  32. J. J. Barry, A. Lembke, and N. Huynh, “Affective Disorders in epilepsy,” in Psychiatric Issues in Epilepsy: A Practical Guide to Diagnosis and Treatment, A. B. Ettinger and A. M. Kanner, Eds., pp. 45–71, Williams & Wilkins, Philadelphia, Pa, USA, 2001. View at Google Scholar
  33. A. M. Kanner and J. C. R. Nieto, “Depressive disorders in epilepsy,” Neurology, vol. 53, no. 2, pp. S26–S32, 1999. View at Google Scholar · View at Scopus
  34. W. A. Lishman, Organic Psychiatry, Blackwell Scientific Publications, Oxford, UK, 3rd edition, 1998.
  35. J. E. Jones, B. P. Hermann, J. J. Barry, F. Gilliam, A. M. Kanner, and K. J. Meador, “Clinical Assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation,” The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 17, no. 2, pp. 172–179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Mula, B. Schmitz, and J. W. Sander, “The pharmacological treatment of depression in adults with epilepsy,” Expert Opinion on Pharmacotherapy, vol. 9, no. 18, pp. 3159–3168, 2008. View at Google Scholar · View at Scopus
  37. Y. I. Sheline, “Neuroimaging studies of mood disorder effects on the brain,” Biological Psychiatry, vol. 54, no. 3, pp. 338–352, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. B. S. McEwen, “Glucocorticoids, depression, and mood disorders: structural remodeling in the brain,” Metabolism, vol. 54, no. 5, pp. S20–S23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Lavretsky, M. Ballmaier, D. Pham, A. Toga, and A. Kumar, “Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study,” The American Journal of Geriatric Psychiatry, vol. 15, no. 5, pp. 386–394, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. S. G. Mueller, K. D. Laxer, N. Schuff, and M. W. Weiner, “Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis,” Epilepsia, vol. 48, no. 2, pp. 220–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. J. D. Bremner, M. Narayan, E. R. Anderson, L. H. Staib, H. L. Miller, and D. S. Charney, “Hippocampal volume reduction in major depression,” The American Journal of Psychiatry, vol. 152, pp. 973–981, 2000. View at Google Scholar · View at Scopus
  42. G. D. Cascino, C. R. Jack Jr., J. E. Parisi et al., “Magnetic resonance imaging based volume studies in temporal lobe epilepsy: pathological correlations,” Annals of Neurology, vol. 30, no. 1, pp. 31–36, 1991. View at Google Scholar · View at Scopus
  43. Y. I. Sheline, P. W. Wang, M. H. Gado, J. G. Csernansky, and M. W. Vannier, “Hippocampal atrophy in recurrent major depression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 9, pp. 3908–3913, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. I. Sheline, M. Sanghavi, M. A. Mintun, and M. H. Gado, “Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression,” Journal of Neuroscience, vol. 19, no. 12, pp. 5034–5043, 1999. View at Google Scholar · View at Scopus
  45. S. A. Baxendale, P. J. Thompson, and J. S. Duncan, “Epilepsy and depression: the effects of comorbidity on hippocampal volume—a pilot study,” Seizure, vol. 14, no. 6, pp. 435–438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. F. Dulay, B. K. Schefft, J. D. Fargo, M. D. Privitera, and H. S. Yeh, “Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy,” Epilepsy & Behavior, vol. 5, no. 4, pp. 522–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Helmstaedter, M. Sonntag-Dillender, C. Hoppe, and C. E. Elger, “Depressed mood and memory impairment in temporal lobe epilepsy as a funtion of focus lateralization and localization,” Epilepsy & Behavior, vol. 5, no. 5, pp. 696–701, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. E. A. Phelps and J. E. LeDoux, “Contributions of the amygdala to emotion processing: from animal models to human behavior,” Neuron, vol. 48, no. 2, pp. 175–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. E. J. Richardson, H. R. Griffith, R. C. Martin et al., “Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy,” Epilepsy & Behavior, vol. 10, no. 2, pp. 242–249, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Tebartz Van Elst, F. G. Woermann, L. Lemieux, and M. R. Trimble, “Amygdala enlargement in dysthymia: a volumetric study of patients with temporal lobe epilepsy,” Biological Psychiatry, vol. 46, no. 12, pp. 1614–1623, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Quiske, C. Helmstaedter, S. Lux, and C. E. Elger, “Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis,” Epilepsy Research, vol. 39, no. 2, pp. 121–125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Mula, M. R. Trimble, and J. W. A. S. Sander, “The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy,” Epilepsia, vol. 44, no. 12, pp. 1573–1577, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. P. C. B. Salgado, C. L. Yasuda, and F. Cendes, “Neuroimaging changes in mesial temporal lobe epilepsy are magnified in the presence of depression,” Epilepsy & Behavior, vol. 19, no. 3, pp. 422–427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Foong and D. Flugel, “Psychiatric outcome of surgery for temporal lobe epilepsy and presurgical considerations,” Epilepsy Research, vol. 75, no. 2-3, pp. 84–96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Altshuler, R. Rausch, S. Delrahim, J. Kay, and P. Crandall, “Temporal lobe epilepsy, temporal lobectomy, and major depression,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 11, no. 4, pp. 436–443, 1999. View at Google Scholar · View at Scopus
  56. K. Malmgren, J. E. Starmark, G. Ekstedt, H. Rosén, and C. Sjöberg-Larsson, “Nonorganic and organic psychiatric disorders in patients after epilepsy surgery,” Epilepsy & Behavior, vol. 3, no. 1, pp. 67–75, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Quigg, D. K. Broshek, S. Heidal-Schiltz, J. W. Maedgen, and E. H. Bertram III, “Depression in intractable partial epilepsy varies by laterality of focus and surgery,” Epilepsia, vol. 44, no. 3, pp. 419–424, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Reuber, B. Andersen, C. E. Elger, and C. Helmstaedter, “Depression and anxiety before and after temporal lobe epilepsy surgery,” Seizure, vol. 13, no. 2, pp. 129–135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. H. A. Ring, J. Moriarty, and M. R. Trimble, “A prospective study of the early postsurgical psychiatric associations of epilepsy surgery,” Journal of Neurology Neurosurgery and Psychiatry, vol. 64, no. 5, pp. 601–604, 1998. View at Google Scholar · View at Scopus
  60. J. Wrench, S. J. Wilson, and P. F. Bladin, “Mood disturbance before and after seizure surgery: a comparison of temporal and extratemporal resections,” Epilepsia, vol. 45, no. 5, pp. 534–543, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. P. A. Derry, K. J. Rose, and R. S. McLachlan, “Moderators of the effect of preoperative emotional adjustment on postoperative depression after surgery for temporal lobe epilepsy,” Epilepsia, vol. 41, no. 2, pp. 177–185, 2000. View at Google Scholar · View at Scopus
  62. Y. Inoue and T. Mihara, “Psychiatric disorders before and after surgery for epilepsy,” Epilepsia, vol. 42, no. 8, pp. 13–18, 2001. View at Google Scholar · View at Scopus
  63. G. N. Meldolesi, G. Di Gennaro, P. P. Quarato et al., “Changes in depression, anxiety, anger, and personality after resective surgery for drug-resistant temporal lobe epilepsy: a 2 year follow up study,” Epilepsy Research, vol. 77, no. 1, pp. 22–30, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Glosser, A. S. Zwil, D. S. Glosser, M. J. O'Connor, and M. R. Sperling, “Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomy,” Journal of Neurology Neurosurgery and Psychiatry, vol. 68, no. 1, pp. 53–58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Irle, M. Peper, B. Wowra, and S. Kunze, “Mood changes after surgery for tumors of the cerebral cortex,” Archives of Neurology, vol. 51, no. 2, pp. 164–174, 1994. View at Google Scholar · View at Scopus
  66. A. M. Pringle, R. Taylor, and I. R. Whittle, “Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery,” The British Journal of Neurosurgery, vol. 13, no. 1, pp. 46–51, 1999. View at Google Scholar · View at Scopus
  67. B. Metternich, K. Wagner, A. Brandt et al., “Preoperative depressive symptoms predict postoperative seizure outcome in temporal and frontal lobe epilepsy,” Epilepsy & Behavior, vol. 16, no. 4, pp. 622–628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J. M. Wrench, G. Rayner, and S. J. Wilson, “Profiling the evolution of depression after epilepsy surgery,” Epilepsia, vol. 52, no. 5, pp. 900–908, 2011. View at Google Scholar
  69. M. Mula and B. Schmitz, “Depression in epilepsy: mechanisms and therapeutic approach,” Therapeutic Advances in Neurological Disorders, vol. 2, no. 5, pp. 337–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. C. L. Melvin, T. S. Carey, F. Goodman, J. M. Oldham, J. W. Williams, and L. M. Ranney, “Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review,” Journal of Psychiatric Practice, vol. 14, supplement 1, pp. 9–14, 2008. View at Google Scholar · View at Scopus
  71. M. Mula, S. Pini, and G. B. Cassano, “The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence,” Journal of Clinical Psychopharmacology, vol. 27, no. 3, pp. 263–272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. D. F. Zullino, Y. Khazaal, J. Hättenschwiler, F. Borgeat, and J. Besson, “Anticonvulsant drugs in the treatment of substance withdrawal,” Drugs of Today, vol. 40, no. 7, pp. 603–619, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. A. D. Lopez, “The global burden of disease 1990–2020. World Health Organization,” in Proceedings of the International Seminar on Nuclear War and Planetary Emergencies, 25th session, pp. 49–50. View at Google Scholar
  74. L. Forsgren and L. Nystrom, “An incident case-referent study of epileptic seizures in adults,” Epilepsy Research, vol. 6, no. 1, pp. 66–81, 1990. View at Publisher · View at Google Scholar · View at Scopus
  75. D. C. Hesdorffer, W. Allen Hauser, E. Olafsson, P. Ludvigsson, and O. Kjartansson, “Depression and suicide attempt as risk factors for incident unprovoked seizures,” Annals of Neurology, vol. 59, no. 1, pp. 35–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. J. K. Austin, J. Harezlak, D. W. Dunn, G. A. Huster, D. F. Rose, and W. T. Ambrosius, “Behavior problems in children before first recognized seizures,” Pediatrics, vol. 107, no. 1, pp. 115–122, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. A. T. McAfee, K. E. Chilcott, C. B. Johannes, K. Hornbuckle, W. A. Hauser, and A. M. Walker, “The incident of first unprovoked seizure in pediatric patients with and without psychiatric distress,” Epilepsia, vol. 48, no. 6, pp. 1075–1082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Alper, K. A. Schwartz, R. L. Kolts, and A. Khan, “Seizure incidence in psychopharmacological clinical trials: an analysis of Food & Drug Administration (FDA) summary basis of approval reports,” Biological Psychiatry, vol. 62, no. 4, pp. 345–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Christensen, M. Vestergaard, P. B. Mortensen, P. Sidenius, and E. Agerbo, “Epilepsy and risk of suicide: a population based case control study,” The Lancet Neurology, vol. 6, no. 8, pp. 693–698, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Christensen, M. Vestergaard, M. C. Petersen, and P. Sidenius, “Epilepsy in Denmark: incidence, prevalence, and validation of diagnosis,” Epilepsia, vol. 46, supplement 6, p. 386, 2005. View at Google Scholar
  81. D. Blumer, G. Montouris, K. Davies, A. Wyler, B. Phillips, and B. Hermann, “Suicide in epilepsy: psychopathology, pathogenesis, and prevention,” Epilepsy & Behavior, vol. 3, no. 3, pp. 232–241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. K. A. Miczek, E. W. Fish, J. F. de Bold, and R. M. M. de Almedia, “Social and neural determnants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine, and gamma aminobutyric acid systems,” Psychopharmacology, vol. 163, pp. 434–458, 2002. View at Google Scholar
  83. M. Pompili, P. Girardi, A. Ruberto, and R. Tatarelli, “Suicide in the epilepsies: a meta-analytic investigation of 29 cohorts,” Epilepsy & Behavior, vol. 7, no. 2, pp. 305–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. J. G. Keilp, H. A. Sackeim, B. S. Brodsky, and M. A. Oquendo, “Prevention of suicide and attempted suicide in Denmark: epidemiological studies of suicide and interventional studies in selected risk groups,” Danish Medical Bulletin, vol. 54, no. 4, pp. 306–359, 2007. View at Google Scholar
  85. J. G. Keilp, H. A. Sackeim, B. S. Brodsky, M. A. Oquendo, K. M. Malone, and J. J. Mann, “Neuropsychological dysfunction in depressed suicide attempters,” The American Journal of Psychiatry, vol. 158, no. 5, pp. 735–741, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Raust, F. Slama, F. Mathieu et al., “Prefrontal cortex dysfunction in patients with suicidal behavior,” Psychological Medicine, vol. 37, no. 3, pp. 411–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. J. E. Jones, B. P. Hermann, J. J. Barry, F. G. Gilliam, A. M. Kanner, and K. J. Meador, “Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy,” Epilepsy & Behavior, vol. 4, no. 3, pp. S31–S38, 2003. View at Google Scholar · View at Scopus
  88. A. G. Espinosa, R. A. Machado, S. B. González, M. E. G. González, A. P. Montoto, and G. T. Sotomayor, “Wisconsin card sorting test performance and impulsivity in patients with temporal lobe epilepsy: suicidal risk and suicide attempts,” Epilepsy & Behavior, vol. 17, no. 1, pp. 39–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. Food & Drug Administration, Office of Biostatistics, “Statistical review and evaluation: antiepileptic drugs and suicidality,” 2008, http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf. View at Google Scholar
  90. X. Wen, K. J. Meador, D. W. Loring, S. Eisenschenk, R. Segal, and A. G. Hartzema, “Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?” Epilepsy & Behavior, vol. 19, no. 3, pp. 494–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Lehrner, R. Kalchmayr, W. Serles et al., “Health related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy,” Seizure, vol. 8, no. 2, pp. 88–92, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. K. Perrine, B. P. Hermann, K. J. Meador et al., “The relationship of neuropsychological functioning to quality of life in epilepsy,” Archives of Neurology, vol. 52, no. 10, pp. 997–1003, 1995. View at Google Scholar · View at Scopus
  93. F. Gilliam, R. Kuzniecky, E. Faught, L. Black, G. Carpenter, and R. Schrodt, “Patient validated content of epilepsy-specific quality of life measurements,” Epilepsia, vol. 38, no. 2, pp. 233–236, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. L. S. Boylan, L. A. Flint, D. L. Labovitz, S. C. Jackson, K. Starner, and O. Devinsky, “Depression but not seizure frequency predicts quality of life in treatment resistant epilepsy,” Neurology, vol. 62, no. 2, pp. 258–261, 2004. View at Google Scholar · View at Scopus
  95. J. A. Cramer, D. Blum, M. Reed et al., “The influence of comorbid depression on quality of life for people with epilepsy,” Epilepsy & Behavior, vol. 4, no. 5, pp. 515–521, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. E. K. Johnson, J. E. Jones, M. Seidenberg, and B. P. Hermann, “The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy,” Epilepsia, vol. 45, no. 5, pp. 544–550, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. A. M. Kanner, F. G. Gilliam, B. Hermann, and K. J. Meador, “Differential effect of mood and anxiety disorders on the quality of life and perception of adverse events to antiepileptic drugs in patients with epilepsy. In: abstracts from the 2007 Annual Meeting of the American Epilepsy Society,” Epilepsia, vol. 48, 6, pp. 1–118, 2007. View at Google Scholar
  98. G. N. Meldolesi, A. Picardi, P. P. Quarato et al., “Factors associated with generic and disease specific quality of life in temporal love epilepsy,” Epilepsy Research, vol. 69, no. 2, pp. 135–146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. A. M. Kanner, “Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy,” Epilepsy & Behavior, vol. 15, no. 1, pp. 83–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. M. R. Salzberg and F. J. E. Vajda, “Epilepsy, depression and antidepressant drugs,” Journal of Clinical Neuroscience, vol. 8, no. 3, pp. 209–215, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. J. D. Leander, “Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116),” Epilepsia, vol. 33, no. 3, pp. 573–576, 1992. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Favale, V. Rubino, P. Mainardi, G. Lunardi, and C. Albano, “Anticonvulsant effect of fluoxetine in humans,” Neurology, vol. 45, no. 10, pp. 1926–1927, 1995. View at Google Scholar · View at Scopus
  103. C. Albano, A. Cupello, P. Mainardi, S. Scarrone, and E. Favale, “Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism,” Neurochemical Research, vol. 31, no. 4, pp. 509–514, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Mula and M. R. Trimble, “Pharmacokinetic interactions between antiepileptic and antidepressant drugs,” The World Journal of Biological Psychiatry, vol. 4, no. 1, pp. 21–24, 2003. View at Google Scholar · View at Scopus
  105. M. Mula and B. Schmitz, “Depression in epilepsy—mechanisms and therapeutic approaches,” European Neurological Disorder, vol. 2, pp. 58–60, 2007. View at Publisher · View at Google Scholar
  106. J. Szymura-Oleksiak, E. Wyska, and A. Wasieczko, “Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression,” Psychopharmacology, vol. 154, no. 1, pp. 38–42, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. C. Fehr, G. Grunder, C. Hiemke, and N. Dahmen, “Increase in serum clomipramine concentrations caused by valproate,” Journal of Clinical Psychopharmacology, vol. 20, no. 4, pp. 493–494, 2000. View at Publisher · View at Google Scholar · View at Scopus
  108. K. U. Kühn, B. B. Quednow, M. Thiel, P. Falkai, W. Maier, and C. E. Elger, “Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants,” Epilepsy & Behavior, vol. 4, no. 6, pp. 674–679, 2003. View at Publisher · View at Google Scholar · View at Scopus